Argenx Se (ARGX) Receivables (2015 - 2025)

Argenx Se (ARGX) posted Receivables of $1.6 billion for Q4 2025, down 99.86% on a QoQ basis from $1197.1 billion in Q2 2025, and up 80.98% year-over-year from $910.1 million in Q4 2024.

Argenx Se (ARGX) Receivables (2015 - 2025) Analysis & Trends

Argenx Se's Receivables history runs 11 years deep, the most recent figure standing at $1.6 billion for Q4 2025.

  • Quarterly Receivables rose 80.98% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (up 80.98% YoY) and the FY2025 annual result came in at $1.6 billion, up 80.98% from the prior year.
  • Receivables was $1.6 billion for Q4 2025 at Argenx Se, down from $1197.1 billion in the prior quarter.
  • Across five years, Receivables topped out at $1197.1 billion in Q2 2025 and bottomed at $12.1 million in Q2 2021.
  • A 5-year average of $120.2 billion and a median of $425.9 million in 2023 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2021 — Receivables grew 27.8% — and 2025, when it soared 183253.63%.
  • Argenx Se's Receivables stood at $39.1 million in 2021, then soared by 608.0% to $276.7 million in 2022, then jumped by 80.2% to $498.6 million in 2023, then jumped by 82.52% to $910.1 million in 2024, then surged by 80.98% to $1.6 billion in 2025.
  • Business Quant data shows ARGX's Receivables at $1.6 billion in Q4 2025, $1197.1 billion in Q2 2025, and $910.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 4.97 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 938.02 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 883.96 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.65 Bn
Jun 30, 2025 1,197.07 Bn
Dec 31, 2024 910.14 Mn
Jun 30, 2024 652.88 Mn
Dec 31, 2023 498.65 Mn
Jun 30, 2023 353.23 Mn
Dec 31, 2022 276.72 Mn
Jun 30, 2022 112.39 Mn
Dec 31, 2021 39.09 Mn
Jun 30, 2021 12.05 Mn
Dec 31, 2020 12.32 Mn
Jun 30, 2020 9.43 Mn
Dec 31, 2019 34.94 Mn
Jun 30, 2019 5.93 Mn
Dec 31, 2018 2.66 Mn
Jun 30, 2018 12.17 Mn
Dec 31, 2017 4.23 Mn
Jun 30, 2017 4.69 Mn
Dec 31, 2016 2.13 Mn
Dec 31, 2015 1.49 Mn